Daewon Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Daewon Pharmaceutical Co Ltd with three other
companies in this sector in South Korea:
IL-Yang Pharmaceutical Company Limited
sales of 269.81 billion Korean Won [US$238.51 million]
of which 100%
was Manufacture of Drugs),
Dong Wha Pharm Company Limited
(258.88 billion Korean Won [US$228.85 million]
Huons Co Ltd
(284.84 billion Korean Won [US$251.80 million]
During the year ended December of 2017, sales at
Daewon Pharmaceutical Co Ltd were 265.46 billion Korean Won (US$234.67 million).
increase of 10.3%
versus 2016, when the company's sales were 240.72 billion Korean Won.
This was the fifth consecutive year of sales increases at Daewon Pharmaceutical Co Ltd
(and since 2012, sales have increased a total of 92%).
Sales of Phamaceutical saw an increase
10.4% in 2017, from
238.45 billion Korean Won to 263.36 billion Korean Won.
Not all segments of Daewon Pharmaceutical Co Ltd experienced an increase in sales in 2017:
sales of Hearing Aid fell 2.0% to 2.27 billion Korean Won.
(However, this segment's sales were only a very small portion of the company's overall sales).